#8: The Machine: Amylin Pharmaceuticals Reports First Quarter Financial Results
SAN DIEGO, April 21 /PRNewswire-FirstCall/ --... |
April 23, 2008
12:56:12 AM |
#7: FastFun: Amylin Pharmaceuticals to Present at Research & Development Day
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,... |
November 28, 2007
09:36:33 PM |
#6: FastFun: Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
Findings validate novel integrated neurohormonal treatment of obesity... |
November 28, 2007
09:33:29 PM |
#5: FastFun: Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
- Both Groups Experienced Significant Weight Loss -
- New Drug... |
November 28, 2007
09:32:48 PM |
#4: FastFun: Amylin Pharmaceuticals to Webcast Third Quarter Results and Gilead Submits Marketing Applications in the United States and European Union for Viread(R) (Tenofovir Disoproxil Fumarate) for the Treatment of Chronic Hepatitis B
Biotechnology industry alert provided by U.S. Equity News. Amylin... |
October 17, 2007
09:27:43 AM |
#3: FastFun: Amylin Pharmaceuticals to Webcast Third Quarter Results
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals,... |
October 17, 2007
09:27:07 AM |
#2: FastFun: Medarex to Present at the Natixis Bleichroeder's Hidden Gems Conference and Amylin Pharma OK's Symlin Pen-Injector Devices
Biotechnology industry alert provided by U.S. Equity News. Medarex, Inc.... |
October 17, 2007
09:25:55 AM |
#1: NewsBot: AMLN News Once Weekly Exenatide LAR Well Tolerated and Improved Glucose Control; Preliminary Results From Phase 2 Study Announced
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 22,... |
August 22, 2005
09:30:00 AM |
| 
| 
| 
| 
| 
| 
